Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
106.1%
-
Total 13F principal
-
$565,996,310
-
Principal change
-
-$21,373,011
-
Total reported market value
-
$601,902,851
-
Number of holders
-
44
-
Value change
-
-$21,072,647
-
Number of buys
-
21
-
Number of sells
-
13
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q2 2017
As of 30 Jun 2017,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
44 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$565,996,310
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, LINDEN ADVISORS LP, Allianz Asset Management GmbH, DEERFIELD MANAGEMENT CO, ADVENT CAPITAL MANAGEMENT /DE/, UBS ASSET MANAGEMENT AMERICAS INC, MACKAY SHIELDS LLC, OAKTREE CAPITAL MANAGEMENT LP, CITADEL ADVISORS LLC, and Calamos Advisors LLC.
This page lists
44
institutional bondholders reporting positions
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.